000 04621nam a22006015i 4500
001 978-3-030-89125-1
003 DE-He213
005 20220712125639.0
007 cr nn 008mamaa
008 211224s2022 sz | s |||| 0|eng d
020 _a9783030891251
_9978-3-030-89125-1
024 7 _a10.1007/978-3-030-89125-1
_2doi
050 4 _aRA421-790.95
072 7 _aMBN
_2bicssc
072 7 _aMED076000
_2bisacsh
072 7 _aMBN
_2thema
082 0 4 _a613
_223
082 0 4 _a614.4
_223
100 1 _aVelásquez, Germán.
_eauthor.
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_91284946
245 1 0 _aVaccines, Medicines and COVID-19
_h[electronic resource] :
_bHow Can WHO Be Given a Stronger Voice? /
_cby Germán Velásquez.
250 _a1st ed. 2022.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2022.
300 _aXVI, 117 p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aSpringerBriefs in Public Health,
_x2192-3701
505 0 _aChapter 1: COVID-19 Vaccines: Between Ethics, Health and Economics -- Chapter 2: Medicines and Intellectual Property: 10 Years of the WHO Global Strategy -- Chapter 3: Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 -- Chapter 4: Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock -- Chapter 5: Intellectual Property and Access to Medicines and Vaccines -- Chapter 6: The World Health Organization Reforms in the Time of COVID-19 -- Epilogue.
506 0 _aOpen Access
520 _aThis open access book is a collection of research papers on COVID-19 by Germán Velásquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership? The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members. In this single volume, the chapters present the progress of thinking and debate - particularly in relation to drugs and vaccines - that would enable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered: COVID-19 Vaccines: Between Ethics, Health and Economics Medicines and Intellectual Property: 10 Years of the WHO Global Strategy Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock Intellectual Property and Access to Medicines and Vaccines The World Health Organization Reforms in the Time of COVID-19 Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice? is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO); World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) staff participating in these negotiations; academics and students of public health, medicine, health sciences, law, sociology and political science; and intergovernmental organizations and non-governmental organizations that follow the issue of access to treatments and vaccines for COVID-19.
650 0 _aMedicine, Preventive.
_9147678
650 0 _aHealth promotion.
_969444
650 0 _aMedical policy.
650 0 _aVaccines-Biotechnology.
_91284947
650 0 _aBiomaterials.
_969650
650 0 _aPublic health.
_96466
650 1 4 _aHealth Promotion and Disease Prevention.
_969448
650 2 4 _aHealth Policy.
_969437
650 2 4 _aBiomaterials-Vaccines.
_91284948
650 2 4 _aPublic Health.
_96466
710 2 _aSpringerLink (Online service)
_923050
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783030891244
776 0 8 _iPrinted edition:
_z9783030891268
830 0 _aSpringerBriefs in Public Health,
_x2192-3701
_91282224
856 4 0 _uhttps://doi.org/10.1007/978-3-030-89125-1
912 _aZDB-2-SME
912 _aZDB-2-SXM
912 _aZDB-2-SOB
999 _c2856373
_d2856373